Septerna
SEPN38.98011.44% ( +4.000 )
Septerna (SEPN)
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment...
- Open
- 35.550
- High
- 39.120
- Low
- 35.550
- Prev. Close
- 34.980
- Volume
- 399.12K
- Turnover
- 15.20M
- Avg Price
- 38.076
- Bid/Ask Ratio
- --
- Amplitude
- 10.21%
- 52wk High
- 39.120
- Volume Ratio
- 1.72
- Turnover Ratio
- 1.72%
Septerna Analyst Rating
View MoreForecast & Rating
Jul 30, 2026Price forecast
$45.0015.44%
Forecast & RatingStrong buy
10analysts
- Strong buy90.00%
- Buy10.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · 13 hours ago
Septerna (NASDAQ:SEPN) Reaches New 12-Month High - Here's What Happened
- Tip Ranks · 20 hours ago
3 Small-Cap Stocks Analysts Expect to Rally Big
- Market Beat · 1 day ago, 04:13 AM
Janus Henderson Group PLC Purchases Shares of 890,754 Septerna, Inc. $SEPN
- Tip Ranks · Jul 20 at 09:15 AM
3 Small-Cap Stocks with 'Strong Buy' Ratings and 40%+ Upside, According to Analysts
- PUBT · Jul 17 at 06:01 PM
Septerna President and COO Elizabeth Bhatt sells 4,000 shares for $135,974
- Simplywall · Jul 11 at 12:18 PM
Is Septerna (SEPN) Fully Valued Following Its Russell Index Inclusions?
